000			05390nam a2200457 i 4500
988			_aSpringer_BiomedLife_2019
999			_c115834 _d115834 _x1
001			115834
003			ESmaUEC
005			20230110040239.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			190831s2019 si | s |||| 0|eng d
020			_a9789811384134
024	7		_a10.1007/978-981-13-8413-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC756 _b2019 EB
245	0	0	_aOxidative stress in lung diseases _nVolume 1 _cedited by Sajal Chakraborti, Tapati Chakraborti, Salil Kumar Das, Dhrubajyoti Chattopadhyay
250			_aFirst edition
264		1	_aSingapore _bSpringer International Publishing _c2019
300			_a1 recurso en línea (XX, 491 páginas) _b74 ilustraciones, 64 ilustraciones a color
336			_aTexto _btxt _2rdacontent
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aPart A. General implications of oxidative stress on lungs -- Chapter 1. The nutrition in inflammatory lung diseases. Chapter 2. Oxidative Stress And Smoke Related Lung Diseases: A Tentative Approaches through blood, lungs and gut -- Chapter 3. Oxidative stress in neonatal lung diseases -- Chapter 4. DNA repair protein OGG1 in pulmonary infection and other inflammatory lung diseases -- Chapter 5. The dual role of oxidative stress in lung cancer -- Chapter 6. Cigarette smoke induced oxidative stress in type I and type II lung epithelial cells -- Chapter 7. Infectious lung diseases and Endogenous oxidative stress -- Chapter 8. Role of MMPs and Oxidants in Lung Diseases -- Chapter 9. Effect of exogenous chemical exposure-response relationship condensate oxidative stress in lung disease -- Part B. Inflammatory lung diseases -- Chapter 10. Oxidative stress and immune regulation during chronic respiratory diseases -- Chapter 11. Immunological basis of oxidative stress induced lung inflammation in asthma and COPD -- Chapter 12. Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases -- Chapter 13. Oxidative Stress and Pulmonary Carcinogenesis through Mechanisms of Reactive Oxygen Species. How Respirable Particulate Matter, Fibrous Dusts and Ozone Cause Pulmonary Inflammation and Initiate Lung Carcinogenesis -- Part C. Other lung diseases -- Chapter 14. The Redoxomics of Bronchopulmonary Dysplasia -- Chapter 15. Oxidative stress in environmental lung diseases -- Chapter 16. Bronchopulmonary Dysplasia and Oxidative Stress in the Newborn -- Chapter 17. Pulmonary Oxidative Stress and Antioxidant Defence System in the Lung Aging, and Fibrotic and Diabetic Lungs -- Chapter 18. Mitochondrial alterations and oxidative stress in cystic fibrosis -- Part D. Degenerative lung diseases -- Chapter 19. Oxidative stress in chronic obstructive pulmonary disease -- Chapter 20. Oxidative stress induced autophagy-impairment and pathogenesis of chronic obstructive lung diseases -- Part E. Prevention and Therapeutics -- Chapter 21. Therapeutic targeting of oxidative stress and inflammation in Asthma and COPD and Pharmacological interventions with Phytochemicals -- Chapter 22. Diallyl trisulfide prospectively rescues Arsenic induced lung oxidative stress, inflammation through the activation of Nrf2/HO-1 signaling -- Chapter 23. Molecular therapeutic targets in tobacco-induced lung pathology. .
520	3		_aThis first volume of the comprehensive, two-volume work on oxidative stress in lung disease introduces the molecular mechanisms, and the role of oxidants in the progression of different lung diseases. The lungs of humans and animals are under constant threat from oxidants from either endogenous (e.g. in situ metabolic reactions) or exogenous sources (e.g. air pollutants). Further, oxidative stress causes the oxidation of proteins, DNA and lipids, which in turn generates secondary metabolic products. The book consists of sections, each focusing on different aspects of oxidant-mediated lung diseases. As such it is a unique reference resource for postgraduate students, biomedical researchers and also for the clinicians who are interested in studying and understanding oxidant-mediated lung diseases. The second volume will incorporate other aspects of oxidant-mediated lung diseases, including prevention and therapeutics. .
650		7	_2embne _aPulmones _xEnfermedades _9168957
650		7	_2embne _aEstrés oxidativo _9158905
650		7	_2embne _aAparato respiratorio _xEnfermedades _9138569
700	1		_aChakraborti, Sajal _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt _984935
700	1		_aChakraborti, Tapati _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aDas, Salil Kumar _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aChattopadhyay, Dhrubajyoti _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9789811384127
776	0	8	_iPrinted edition: _z9789811384141
776	0	8	_iPrinted edition: _z9789811384158
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-8413-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _cm _dz _feng _ggw _h0 _b01/2020 _eel _zSI